Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Stomatitis 2Recurrence 2Nasopharyngeal Carcinoma 2Meningeal Carcinomatosis 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Anemia 2Vitamin B 12 Deficiency 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thrombocytopenia 1Stroke 1Stomach Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Papillomavirus Infections 1Ovarian Neoplasms 1Oligodendroglioma 1Neutropenia 1Neuralgia 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myocardial Infarction 1Mesothelioma 1Head and Neck Neoplasms 1HR-positive Breast Cancer 1Gliosarcoma 1

Interventions

Aspirin 2Vitamin E 1Vitamin B 6 1Vitamin B 12 1Standard of Care 1Sodium Bicarbonate 1Saline Solution 1Observation 1Folic Acid 1Fluoridation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myocardial Infarction × Vitamin B 12 × Clear all
NCT00106886 2005-09-20

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

McMaster University

Phase 4 Unknown
5,000 enrolled

Cardiovascular Diseases, Myocardial Infarction, Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡